How to Test Human-Specific Combination Immunotherapies In Vivo
Por um escritor misterioso
Descrição
Learn how to evaluate combinations of human-specific checkpoint inhibitors in vivo, with double knock-in humanized drug target mouse models.
Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12
STING activation promotes robust immune response and NK cell–mediated tumor regression in glioblastoma models
IJMS, Free Full-Text
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment
Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies
Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV- specific CD8+ T cells in people living with HIV - eBioMedicine
In Vitro T Cell Killing Assay Protocol Using Millicell® Microwell Plates
Inducing CAR-macrophages in the brain for local treatment
IJMS, Free Full-Text
Development of humanized mouse with patient‐derived xenografts for cancer immunotherapy studies: A comprehensive review - Jin - 2021 - Cancer Science - Wiley Online Library
Antibodies, Free Full-Text
InVivoMAb anti-mouse Ly6G
Frontiers Advances in Human Dendritic Cell-Based Immunotherapy Against Gastrointestinal Cancer
de
por adulto (o preço varia de acordo com o tamanho do grupo)
